The amount of miR-21 in tumor tissue was significantly different in patients with a HER2 level estimated at a 0 score according to the IHC, from the amount of miRNA in patients with HER2-amplified BC or HER2 1+ BC (Figure 10). The gene discussed is ERBB2; the disease is breast cancer.